Brownstein Policy Directors Cate McCanless and Drew Littman with Policy Advisor Laura Johnson join Strategic Advisor Mark Begich to discuss the latest health care issues in Washington, including ACA stabilization efforts again falling short, where these efforts wind up in the wake of potential premium increases leading up to the 2018 midterm elections and the regulatory patchwork playing out as states seek both Medicaid expansion and 1332 waivers. The team also offers their insights into the administration’s announcement on drug pricing and the likelihood of legislative or administrative action.